• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Biotech Market
    Biotech News
    Biotech Stocks
    • Biotech Market
    • Biotech News
    • Biotech Stocks

    Alimera Sciences Refinances Debt Facility With Solar Capital

    Danielle Edwards
    Jan. 06, 2020 06:08AM PST
    Biotech Investing

    Alimera announced it has entered into a new US$45 million term loan agreement with investment affiliates managed by Solar Capital Partners.

    Alimera Sciences (NASDAQ:ALIM) announced that it refinanced its debt facility by entering into a new US$45 million term loan agreement with investment affiliates managed by Solar Capital Partners.

    As quoted in the press release:

    The amount of the new funding includes an initial tranche of $42.5 million used to repay the current facility, including principal, prepayment fees and accrued interest, and another $2.5 million tranche that will be available if Alimera achieves $30.0 million in revenue for any trailing six-month period ending on or before November 30, 2020.

    The new loan agreement has a term of 54 months to July 1, 2024, with monthly interest-only payments to January 1, 2023, when principal amortization begins. The interest-only period may be extended an additional six months if Alimera achieves $34.5 million in revenue for any trailing six-month period ending on or before June 30, 2022.

    Click here to read the full press release.

    nasdaq:alimalimera sciences
    The Conversation (0)

    Go Deeper

    AI Powered
    Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights 

    Mereo BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Highlights 

    Bridge Renewable Energy Announces the Closing of an $80M Term Loan Facility to Support the Construction of a 40 MW Distributed Energy Solar and Battery Storage Portfolio

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES